Isolated soy protein improves endothelial function in postmenopausal hypercholesterolemic women
- 24 July 2003
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 57 (8) , 889-894
- https://doi.org/10.1038/sj.ejcn.1601622
Abstract
Background: Postmenopausia and hypercholesterolemia are related to endothelial dysfunction, a pathogenic event in atherosclerosis. Soy protein reduces plasma cholesterol, but there is scanty information about its effect on endothelial function. Objective: To evaluate the effect of isolated soy protein compared to caseinate on plasma lipoproteins and endothelial function in postmenopausal hypercholesterolemic women. Design: Randomized, double-blind, cross-over trial. Setting: Outpatient clinic of the Catholic University of Chile. Subjects: Eighteen healthy, postmenopausal women with hypercholesterolemia were recruited, included and completed the protocol. Interventions: During the trial, all patients followed a low fat/low cholesterol diet and were randomly assigned to receive isolated soy protein or matching caseinate for 4 weeks, and then the alternative treatment until week 8. At pre-study and at the end of the first and second period, plasma lipoprotein levels and endothelial function (flow-mediated dilatation (FMD) of the brachial artery) were evaluated. Results: Plasma total and low density lipoprotein (LDL)-cholesterol concentration were significantly lower with the low fat/low cholesterol diet compared to pre-study, either with caseinate or soy protein. No significant differences in plasma lipid concentration between caseinate or soy protein interventions were observed. FMD did not change with the caseinate. In contrast, when soy protein was administered, FMD was significantly higher compared to pre-study (9.471.8% vs 5.371.2%; Pvs 4.971.5%; P<0.033). Conclusions: These results suggest that in postmenopausal hypercholesterolemic women, soy protein improves endothelial function, regardless of changes in plasma lipoproteins. Sponsorship: Pontificia Universidad Católica (DIPUC99/09E), Protein Technology International and Gynopharm Laboratory (Recalcine Group).Keywords
This publication has 26 references indexed in Scilit:
- Noncardiovascular Disease Outcomes During 6.8 Years of Hormone TherapyJAMA, 2002
- Disfunción endotelial como alteración primaria en las patologías vascularesRevista médica de Chile, 2000
- Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart DiseaseCirculation, 2000
- Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and βProceedings of the National Academy of Sciences, 1999
- Endothelial Dysfunction: From Physiology to TherapyJournal of Molecular and Cellular Cardiology, 1999
- Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaquesFertility and Sterility, 1997
- High density lipoproteins and coronary heart diseaseAtherosclerosis, 1996
- Meta-Analysis of the Effects of Soy Protein Intake on Serum LipidsNew England Journal of Medicine, 1995
- Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal WomenAnnals of Internal Medicine, 1994
- Effect of Dietary Stearic Acid on Plasma Cholesterol and Lipoprotein LevelsNew England Journal of Medicine, 1988